More
    Guided Solutions - Connecting Talent With Innovation/div>

    ANEUVO secures Series C funding to strengthen ExaStim

    ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, announced the closing of a Series C funding round of $22M led by Catcher Technology Co., Ltd., with participation...

    ANEUVO secures Series C funding to strengthen ExaStim

    ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, announced the closing of a Series C funding round...

    Cognito Therapeutics raises $105M for Alzheimer’s therapeutic advancement

    Cognito Therapeutics has raised $105m to advance the clinical development and commercial preparedness for its Alzheimer’s disease therapeutic. The Massachusetts-based company’s oversubscribed Series C financing...

    GS MedTech Funding Tracker – Science, Polares, and more

    Significant funding rounds are powering the next wave of innovation this week in MedTech - from brain-computer interfaces and muscle-computer tech to structural heart...

    Science Corporation closes $230M Series C to support BCI tech

    Science Corporation announced that it closed an oversubscribed $230 million Series C financing round. Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT and Quiet Capital,...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

    VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

    Kandu trial highlights positive outcomes with IpsiHand BCI system

    Kandu Health announced positive results from the first randomized controlled trial of its brain-computer interface (BCI) therapy. The trial evaluated its FDA-cleared, non-invasive IpsiHand BCI...

    Innovation

    Regulatory Approvals

    ANEUVO secures Series C funding to strengthen ExaStim

    ANEUVO, a medical technology company advancing non-invasive neuromodulation for people living with spinal cord injury, announced the closing of a Series C funding round...

    Cognito Therapeutics raises $105M for Alzheimer’s therapeutic advancement

    Cognito Therapeutics has raised $105m to advance the clinical development and commercial preparedness for its Alzheimer’s disease therapeutic. The Massachusetts-based company’s oversubscribed Series C financing...

    GS MedTech Funding Tracker – Science, Polares, and more

    Significant funding rounds are powering the next wave of innovation this week in MedTech - from brain-computer interfaces and muscle-computer tech to structural heart...

    Science Corporation closes $230M Series C to support BCI tech

    Science Corporation announced that it closed an oversubscribed $230 million Series C financing round. Lightspeed Venture Partners, Khosla Ventures, Y Combinator, IQT and Quiet Capital,...

    M&A

    Archives

    Latest articles